Literature DB >> 9655894

Crosstalk between alpha-1A and alpha-1B adrenoceptors in neonatal rat myocardium: implications in cardiac hypertrophy.

X F Deng1, A Sculptoreanu, S Mulay, K G Peri, J F Li, W H Zheng, S Chemtob, D R Varma.   

Abstract

The myocardial effect of alpha-1A adrenoceptor (alpha-1 AR) agonists in neonatal rats are mediated by alpha-1A AR and not by alpha-1B AR, although both receptor subtypes are equally expressed; the functions of alpha-1B AR are not known. Here, we report that alpha-1 B ARs inhibit the activities of alpha-1A ARs in neonatal rat myocardium so that the inactivation of alpha-1 B ARs by chloroethylclonidine (CEC) potentiated the effects of nonselective alpha-1 AR agonist phenylephrine (PE) on myocardial protein synthesis and early gene (c-fos and c-jun) expression. CEC did not modify the hypertrophic effect of angiotensin II. The potentiation of the effects of PE by CEC was associated with a translocation of Ca(++)-dependent protein kinase C (PKC)alpha, which did not occur in the absence of CEC. Alpha-1A AR-selective agonist A61603 was approximately 1000-fold more potent than PE as a positive inotropic agent; it caused the translocation of PKC alpha, which was not affected by CEC. 5-Methylurapidil antagonized the effects of PE and A61603, suggesting that these were mediated via alpha-1A ARs. Alpha-1D AR antagonist BMY 7378 did not modify PE-induced translocation of PKC. CEC potentiated the effects of PE on Ca++ transients in Fura 2-AM-loaded dispersed cardiomyocytes, and this potentiation was prevented by nifedipine. In whole-cell patch-clamp recordings of cultured cardiomyocytes, CEC potentiated the effect of norepinephrine on Ca++ channel currents, which was blocked by 5-methylurapidil. We conclude that alpha-1A ARs are positively and alpha-1B ARs are negatively coupled to nifedipine-sensitive Ca++ channels, possibly via Gi protein, and this antagonistic relationship between alpha-A AR and alpha-1B AR in the neonatal heart might be required physiologically for normal alpha-1 AR-mediated responses and myocardial development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655894

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Inhibition of the alpha(1D)-adrenergic receptor gene by RNA interference (RNAi) in rat vascular smooth muscle cells and its effects on other adrenergic receptors.

Authors:  Bei Sun; Ekaterina Kintsurashvili; Deborah Ona; Ivana Ignjacev-Lazich; Irene Gavras; Haralambos Gavras
Journal:  Vascul Pharmacol       Date:  2007-01-23       Impact factor: 5.773

2.  Intraventricular and interventricular cellular heterogeneity of inotropic responses to α(1)-adrenergic stimulation.

Authors:  Charles Chu; Kevin Thai; Ki Wan Park; Paul Wang; Om Makwana; David H Lovett; Paul C Simpson; Anthony J Baker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-25       Impact factor: 4.733

3.  The contribution of α1B-adrenoceptor subtype in the renal vasculature of fructose-fed Sprague-Dawley rats.

Authors:  Mohammed H Abdulla; Munavvar A Sattar; Nor A Abdullah; Md Abdul Hye Khan; Kolla R L Anand Swarup; Edward J Johns
Journal:  Eur J Nutr       Date:  2010-09-30       Impact factor: 5.614

4.  Impaired IKs channel activation by Ca(2+)-dependent PKC shows correlation with emotion/arousal-triggered events in LQT1.

Authors:  Jin O-Uchi; J Jeremy Rice; Martin H Ruwald; Xiaorong Xu Parks; Elsa Ronzier; Arthur J Moss; Wojciech Zareba; Coeli M Lopes
Journal:  J Mol Cell Cardiol       Date:  2014-12-02       Impact factor: 5.000

5.  Adrenergic Receptor Regulation of Mitochondrial Function in Cardiomyocytes.

Authors:  Peyton B Sandroni; Kelsey H Fisher-Wellman; Brian C Jensen
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

Review 6.  Adrenergic signaling in heart failure: a balance of toxic and protective effects.

Authors:  Anthony J Baker
Journal:  Pflugers Arch       Date:  2014-03-14       Impact factor: 3.657

7.  PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2).

Authors:  Julian C Braz; Orlando F Bueno; Leon J De Windt; Jeffery D Molkentin
Journal:  J Cell Biol       Date:  2002-02-25       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.